| I |
A3880 |
ADIFAB fatty acid indicator |
200 μg |
| A |
A47 |
1-anilinonaphthalene-8-sulfonic acid (1,8-ANS) *high purity* |
100 mg |
| A |
A50 |
2-anilinonaphthalene-6-sulfonic acid (2,6-ANS) |
100 mg |
| R |
B13950 |
BODIPY FL C5-ganglioside GM1 |
25 μg |
| A |
B153 |
bis-ANS (4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid, dipotassium salt) |
10 mg |
| P |
B1616 |
N-((6-(biotinoyl)amino)hexanoyl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt (biotin-X DHPE) |
5 mg |
| M |
B24570 |
bis-(1,3-dibutylbarbituric acid)trimethine oxonol (DiBAC4(3)) *FluoroPureTM grade* |
5 mg |
| A |
B311 |
1,3-bis-(1-pyrenyl)propane |
25 mg |
| M |
B413 |
bis-(1,3-diethylthiobarbituric acid)trimethine oxonol (DiSBAC2(3)) |
100 mg |
| M |
B438 |
bis-(1,3-dibutylbarbituric acid)trimethine oxonol (DiBAC4(3)) |
25 mg |
| N, R |
C22841 |
cholera toxin subunit B (recombinant), Alexa Fluor 488 conjugate |
500 μg |
| N, R |
C22842 |
cholera toxin subunit B (recombinant), Alexa Fluor 594 conjugate |
500 μg |
| N, R |
C22843 |
cholera toxin subunit B (recombinant), Alexa Fluor 555 conjugate |
500 μg |
| N, R |
C34775 |
cholera toxin subunit B (recombinant), Alexa Fluor 488 conjugate |
100 μg |
| N, R |
C34776 |
cholera toxin subunit B (recombinant), Alexa Fluor 555 conjugate |
100 μg |
| N, R |
C34777 |
cholera toxin subunit B (recombinant), Alexa Fluor 594 conjugate |
100 μg |
| N, R |
C34778 |
cholera toxin subunit B (recombinant), Alexa Fluor 647 conjugate |
100 μg |
| N, R |
C34779 |
cholera toxin subunit B (recombinant), biotin-XX conjugate |
100 μg |
| N, R |
C34780 |
cholera toxin subunit B (recombinant), horseradish peroxidase conjugate |
100 μg |
| S |
C3927MP |
cholesteryl 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-dodecanoate (cholesteryl BODIPYR FL C13) |
1 mg |
| N |
C7000 |
CellTracker CM-DiI *special packaging* |
20 x 50 μg |
| N |
C7001 |
CellTrackerTM CM-DiI |
1 mg |
| A |
D109 |
5-dodecanoylaminofluorescein |
100 mg |
| M |
D1199 |
di-4-ANEPPS |
5 mg |
| A |
D250 |
6-dodecanoyl-2-dimethylaminonaphthalene (laurdan) |
100 mg |
| N |
D275 |
3,3'-dioctadecyloxacarbocyanine perchlorate ('DiO'; DiOC18(3)) |
100 mg |
| N |
D282 |
1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate ('DiI'; DiIC18(3)) |
100 mg |
| M |
D306 |
3,3'-dipropylthiadicarbocyanine iodide (DiSC3(5)) |
100 mg |
| M |
D3167 |
di-8-ANEPPS |
5 mg |
| F |
D3823 |
4,4-difluoro-5-methyl-4-bora-3a,4a-diaza-s-indacene-3-dodecanoic acid (C1-BODIPYR 500/510 C12) |
1 mg |
| A |
D3922 |
4,4-difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene (BODIPYR 493/503) |
10 mg |
| P |
D476 |
2-(3-(diphenylhexatrienyl)propanoyl)-1-hexadecanoyl-sn-glycero-3-phosphocholine (s-DPH HPC) |
1 mg |
| P |
D57 |
N-(5-dimethylaminonaphthalene-1-sulfonyl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt (dansyl DHPE) |
25 mg |
| M |
D6923 |
di-2-ANEPEQ (JPW 1114) |
5 mg |
| N |
D7757 |
1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine, 4-chlorobenzenesulfonate salt ('DiD' solid; DiIC18(5) solid) |
10 mg |
| N |
F35355 |
FMR 1-43FX *fixable analog of FMR 1-43 membrane stain* |
10 x 100 μg |
| P |
F362 |
N-(fluorescein-5-thiocarbamoyl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt (fluorescein DHPE) |
5 mg |
| P |
L1392 |
Lissamine rhodamine B 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt (rhodamine DHPE) |
5 mg |
| A |
N1142 |
nile red |
25 mg |
| S |
N1148 |
22-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-23,24-bisnor-5-cholen-3s-ol (NBD cholesterol) |
10 mg |
| S |
N3524 |
6-((N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl)sphingosyl phosphocholine (NBD C6-sphingomyelin) |
1 mg |
| P |
N360 |
N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt (NBD-PE) |
10 mg |
| A |
O246 |
octadecyl rhodamine B chloride (R18) |
10 mg |
| A |
P248 |
6-propionyl-2-dimethylaminonaphthalene (prodan) |
100 mg |
| A |
P459 |
3-(4-(6-phenyl)-1,3,5-hexatrienyl)phenylpropionic acid (DPH propionic acid) |
25 mg |
| M |
R649 |
RH 795 |
1 mg |
| M |
T1111 |
N-(3-triethylammoniumpropyl)-4-(4-(4-(diethylamino) phenyl) butadienyl) pyridinium dibromide (RH 414) |
5 mg |
| N |
T13320 |
N-(3-triethylammoniumpropyl)-4-(6-(4-(diethylamino)phenyl)hexatrienyl) pyridinium dibromide (FMR 4-64) *special packaging* |
10 x 100 μg |
| P |
T1395MP |
Texas Red 1,2-dihexadecanoyl-sn-glycero-3-phophoethanolamine, triethylammonium salt (Texas RedR DHPE) |
1 mg |
| A |
T204 |
1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene p-toluenesulfonate (TMA-DPH) |
25 mg |
| N |
T3163 |
N-(3-triethylammoniumpropyl)-4-(4-(dibutylamino)styryl)pyridinium dibromide (FMR 1-43) |
1 mg |
| N |
T3166 |
N-(3-triethylammoniumpropyl)-4-(6-(4-(diethylamino) phenyl) hexatrienyl) pyridinium dibromide (FMR 4-64) |
1 mg |
| N |
T35356 |
N-(3-triethylammoniumpropyl)-4-(4-(dibutylamino)styryl)pyridinium dibromide (FMR 1-43) *special packaging* |
10 x 100 μg |
| N |
V22885 |
Vybrant DiI cell-labeling solution |
1 mL |
| N |
V22886 |
Vybrant DiO cell-labeling solution |
1 mL |
| N |
V22887 |
Vybrant DiD cell-labeling solution |
1 mL |
| N |
V22888 |
Vybrant CM-DiI cell-labeling solution |
1 mL |
| N |
V22889 |
Vybrant Multicolor Cell-Labeling Kit *DiO, DiI, DiD solutions, 1 mL each* |
1 kit |
| R |
V34403 |
Vybrant Alexa Fluor 488 Lipid Raft Labeling kit *50 labelings* |
1 kit |
| R |
V34404 |
Vybrant Alexa Fluor 555 Lipid Raft Labeling kit *50 labelings* |
1 kit |
| R |
V34405 |
Vybrant Alexa Fluor 594 Lipid raft labeling kit *50 labelings* |
1 kit |